Enrico Di Cera

Title: Enrico Di Cera - Innovator in Anticoagulation Research

Introduction

Enrico Di Cera, an accomplished inventor based in Ladue, Missouri, has made significant contributions to the field of anticoagulation research. With a total of three patents to his name, Di Cera continues to push the boundaries of medical science, focusing primarily on improving blood coagulation management.

Latest Patents

Di Cera's most recent patents highlight his innovative approach to regulating the blood coagulation pathway. One notable patent discusses the creation of thrombin-thrombomodulin fusion proteins that serve as powerful anticoagulants. This innovation involves compositions and methods designed to use these fusion proteins not only for treating sepsis but also as effective blood anticoagulants. Another patent from Di Cera focuses on thrombin-thrombomodulin fusion proteins as protein C activators, detailing methods for their preparation, as well as tools for measuring protein C levels in plasma, which can be crucial for diagnosing and managing coagulation disorders.

Career Highlights

Enrico Di Cera has established himself as a notable figure in his field while working at Saint Louis University. His academic and research endeavors have significantly advanced our understanding of blood coagulation. Through his inventions, he aims to provide solutions that can enhance patient care, particularly for those suffering from blood-related conditions.

Collaborations

Throughout his career, Di Cera has collaborated with esteemed colleagues such as Nicola Pozzi and Sergio Barranco-Medina. These partnerships reflect a shared commitment to advancing research and developing new therapies that can improve patient outcomes.

Conclusion

Enrico Di Cera’s innovative work on thrombin-thrombomodulin fusion proteins underscores the critical role of inventors in the medical field. His patents not only represent personal academic accomplishments but also reflect a broader impact on healthcare, helping to pave the way for new treatments in anticoagulation therapy. As he continues his work at Saint Louis University, the medical community looks forward to further advancements brought about by his research and innovations.